Body weight and blood pressure changes on dolutegravir‐, efavirenz‐ or atazanavir‐based antiretroviral therapy in Zimbabwe: a longitudinal study

Abstract Introduction Dolutegravir (DTG) is widely used for antiretroviral therapy (ART). We compared weight and blood pressure trends and examined the association between high blood pressure and weight gain among people living with HIV (PLHIV) switching to or starting DTG‐based, efavirenz (EFV)‐bas...

Descripció completa

Dades bibliogràfiques

Autors principals:	Tinei Shamu, Matthias Egger, Tinashe Mudzviti, Cleophas Chimbetete, Justen Manasa, Nanina Anderegg
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2024-02-01
Col·lecció:	Journal of the International AIDS Society
Matèries:	HIV dolutegravir blood pressure hypertension body weight Zimbabwe
Accés en línia:	https://doi.org/10.1002/jia2.26216
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!